William leverages on his strong scientific background to evaluate the technology and IP of many young companies.
Prior to Ginward, William invented a unique drug screening platform for demyelinating diseases to remove the need for animal testing. William also engineered an artificial axon platform, which models dysregulation in the central nervous system mechanical environment as a result of traumatic injuries and disorders. He was among a group of pioneering scientists to demonstrate the pivotal role of mechanical stiffness in the central nervous system myelination. He worked with renowned international researchers from top universities and research institutions in Singapore, US, UK and China.
William’s contribution to the central nervous system research is evident in 9 tier-1 academic publications, including lead authorships in top international journals such as Acta Biomaterialia and Advanced Drug Delivery Reviews. He was invited to speak at the Gordon Research Conferences in Los Angeles and TERMIS Asia Pacific in Taipei on his inventions.
William was awarded the prestigious ASEAN Scholarship and ASEAN Undergraduate Scholarship from 2005 to 2015 by the Ministry of Education, Singapore. He worked for GSK Singapore in the engineering services department and earned the CFA Institute Investment Foundations certificate.
He holds a Ph.D. in Biomedical Sciences and Engineering, Research Scholar from Nanyang Technological University as well as Bachelor’s in Chemical Engineering with First Class honours.
